| Jump to: | Authorized Access | | | Attribution | | | Authorized Requests |
- Study Description
-
Important Links and Information
-
Request access via Authorized Access
- Instructions for requestors
- Data Use Certification (DUC) Agreement
- Talking Glossary of Genetic Terms
Mammalian fetal lung development is a complex biological process. Despite considerable progress, a comprehensive understanding of the dynamic regulatory networks that govern postnatal alveolar lung development is still lacking. The purpose of this study as part of the LungMAP consortium (www.lungmap.net) is to understand the transcriptional changes in the process of mammalian lung development.
- Study Weblinks:
- Study Design:
- Control Set
- Study Type:
- Longitudinal
- Total number of consented subjects: 10
- Subject Sample Telemetry Report (SSTR)
-
Request access via Authorized Access
- Authorized Access
- Publicly Available Data
- Study Inclusion/Exclusion Criteria
Pathological human specimens were selected based on age, disease status and potential confounding variables.
- Selected Publications
- Diseases/Traits Related to Study (MeSH terms)
-
- Primary Phenotype: Lung
- Authorized Data Access Requests
- Study Attribution
-
-
Principal Investigators
- Bruce Aronow, PhD. Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA.
- Nathan Salomonis, PhD. Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA.
-
Funding Source
- U24HL14886502. National Institutes of Health, Bethesda, MD, USA.
-
Principal Investigators